CompuMed (OTCMKTS:CMPD) Trading 7.1% Higher – Still a Buy?

CompuMed Inc. (OTCMKTS:CMPDGet Free Report)’s stock price shot up 7.1% during trading on Monday . The stock traded as high as $5.95 and last traded at $5.55. 7,202 shares changed hands during trading, an increase of 198% from the average session volume of 2,417 shares. The stock had previously closed at $5.18.

CompuMed Stock Up 7.1%

The firm’s 50 day simple moving average is $4.54 and its 200-day simple moving average is $3.93. The company has a market cap of $7.38 million, a price-to-earnings ratio of -110.98 and a beta of -0.30. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.28 and a quick ratio of 2.26.

CompuMed (OTCMKTS:CMPDGet Free Report) last posted its earnings results on Friday, February 13th. The company reported $0.02 earnings per share for the quarter. The business had revenue of $2.10 million during the quarter. CompuMed had a negative return on equity of 1.82% and a negative net margin of 0.78%.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

See Also

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.